Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study.
Laura PazzagliMorten AndersenMaurizio SessaPublished in: Pharmacoepidemiology and drug safety (2021)
This study showed that not adding the gap at the end of the treatment episodes leads to an overestimation of drug discontinuation, particularly at the beginning of the observational window, and an underestimation of the incidence rate of a hypothetical outcome during the period of exposure to the medication.